Glenmark Pharmaceuticals Stock Forecast 2024-2050: Technical Analysis and Long-Term Targets
Glenmark Pharmaceuticals is an Indian multinational pharmaceutical company. Glenmark Pharmaceuticals is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
This detailed post will explore Glenmark Pharmaceuticals’s share price targets from 2024 to 2050, using various technical analysis approaches to provide long-term forecasts and predict targets up to 2050.
Overview of Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited was the fifth-largest pharmaceutical company in India and ranks among the top five fastest-growing companies in the Indian pharma market. It is a global, integrated, and innovation-driven organization with a strong presence in major markets worldwide.
The company primarily focuses on building a global business in branded generics, generics, specialty, and OTC products, particularly in the fields of dermatology, respiratory medicine, and oncology. Additionally, Glenmark has a strong regional or country-specific presence in other therapeutic areas such as diabetes, cardiovascular disease, and oral contraceptives.
| Company Name | Glenmark Pharmaceuticals Limited |
| Industry | Pharmaceuticals |
| Founded | 1977 |
| Country | India |
| Official Website | www.glenmarkpharma.com |
On this page, you’ll find comprehensive information about the company’s current stock price, live charts, and the latest forecasts for both short- and long-term periods:
- Real-Time Stock Price: Updated every minute for the most current data.
- Technical Indicators: Updated according to specific time frames to provide timely insights.
- Financial Reports: Updated quarterly to reflect the latest financial performance.
- Stock Charts: Refreshed every minute for up-to-the-minute visual data.
Glenmark Pharmaceuticals Stock Price Forecast for Tomorrow and the Coming Week Based on the Last 30 Days.
Technical Analysis of Glenmark Pharmaceuticals Based on Indicators
You can use indicator-based technical analysis for Glenmark Pharmaceuticals Ltd. to identify better entry points in the market. Adjust the time frame to suit your needs for the best analysis.
Glenmark Pharmaceutical technical analysis signals are categorized to help you easily understand the market trends:
- “Sell” or “Strong Sell”: Indicates that most signals are bearish (negative).
- “Buy” or “Strong Buy”: Indicates that most signals are bullish (positive).
Keep in mind that signals can vary across different time frames. For short-term analysis, it’s recommended to use settings ranging from 15 minutes to 2 hours. If you’re planning to hold Glenmark Pharmaceuticals Ltd. stock for more than a week, use settings that range from days to weeks.
Glenmark Pharmaceuticals Ltd. Financials Data
Use the landscape mode for best viewing on mobile devices.
Glenmark Pharmaceuticals Share Price Targets: 2024 to 2050 Snapshot
| Year | Minimum Price | Maximum Price |
|---|---|---|
| 2024 | ₹ 1,676 | ₹ 1,728 |
| 2025 | ₹ 1,701 | ₹ 1,891 |
| 2026 | ₹ 1,865 | ₹ 2,055 |
| 2027 | ₹ 2,030 | ₹ 2,218 |
| 2028 | ₹ 2,193 | ₹ 2,381 |
| 2029 | ₹ 2,357 | ₹ 2,683 |
| 2030 | ₹ 2,623 | ₹ 3,040 |
| 2040 | ₹ 9,227 | ₹ 11,474 |
| 2050 | ₹ 32,461 | ₹ 43,301 |
These “Glenmark Pharmaceuticals Limited” price targets are for reference purposes only. Short-term and long-term Glenmark Pharmaceuticals stock price predictions may vary due to the time series that were analyzed differently. This prediction assumes positive market sentiments, and this analysis does not cover any uncertainties in the company or global market conditions.
Glenmark Pharmaceuticals Share Price Target 2024
| Months | Minimum Price | Maximum Price |
|---|---|---|
| October 2024 | ₹ 1,676 | ₹ 1,682 |
| November 2024 | ₹ 1,683 | ₹ 1,696 |
| December 2024 | ₹ 1,697 | ₹ 1,728 |
● The initial price target for Glenmark Pharmaceuticals Limited in 2024 is estimated to be ₹1682.
● However, by the end of 2024, the price target is anticipated to rise to ₹1728 driven by bullish market trends.
Glenmark Pharmaceuticals Share Price Target 2025
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2025 | ₹ 1,704 | ₹ 1,728 |
| February 2025 | ₹ 1,701 | ₹ 1,713 |
| March 2025 | ₹ 1,714 | ₹ 1,728 |
| April 2025 | ₹ 1,732 | ₹ 1,775 |
| May 2025 | ₹ 1,766 | ₹ 1,777 |
| June 2025 | ₹ 1,780 | ₹ 1,814 |
| July 2025 | ₹ 1,816 | ₹ 1,853 |
| August 2025 | ₹ 1,853 | ₹ 1,871 |
| September 2025 | ₹ 1,831 | ₹ 1,847 |
| October 2025 | ₹ 1,839 | ₹ 1,846 |
| November 2025 | ₹ 1,848 | ₹ 1,859 |
| December 2025 | ₹ 1,860 | ₹ 1,891 |
● The initial price target for Glenmark Pharmaceuticals Limited in 2025 is estimated to be ₹1728.
● With favorable market conditions, the mid-year price target for Glenmark Pharmaceuticals Ltd. could reach ₹1814.
● However, by the end of 2025, the price target is expected to reach ₹1891 considering bullish market trends.
Glenmark Pharmaceuticals Share Price Target 2026
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2026 | ₹ 1,869 | ₹ 1,893 |
| February 2026 | ₹ 1,865 | ₹ 1,877 |
| March 2026 | ₹ 1,877 | ₹ 1,893 |
| April 2026 | ₹ 1,893 | ₹ 1,940 |
| May 2026 | ₹ 1,930 | ₹ 1,940 |
| June 2026 | ₹ 1,943 | ₹ 1,979 |
| July 2026 | ₹ 1,978 | ₹ 2,018 |
| August 2026 | ₹ 2,014 | ₹ 2,035 |
| September 2026 | ₹ 1,995 | ₹ 2,013 |
| October 2026 | ₹ 2,003 | ₹ 2,009 |
| November 2026 | ₹ 2,011 | ₹ 2,023 |
| December 2026 | ₹ 2,024 | ₹ 2,055 |
● The initial price target for Glenmark Pharmaceuticals Limited in 2026 is estimated to be ₹1893.
● With favorable market conditions, the mid-year price target for Glenmark Pharmaceuticals Ltd. could reach ₹1979.
● However, by the end of 2026, the price target is expected to reach ₹2055 considering bullish market trends.
Glenmark Pharmaceuticals Share Price Target 2027
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2027 | ₹ 2,034 | ₹ 2,057 |
| February 2027 | ₹ 2,030 | ₹ 2,040 |
| March 2027 | ₹ 2,041 | ₹ 2,055 |
| April 2027 | ₹ 2,056 | ₹ 2,104 |
| May 2027 | ₹ 2,094 | ₹ 2,105 |
| June 2027 | ₹ 2,108 | ₹ 2,141 |
| July 2027 | ₹ 2,141 | ₹ 2,180 |
| August 2027 | ₹ 2,180 | ₹ 2,200 |
| September 2027 | ₹ 2,158 | ₹ 2,176 |
| October 2027 | ₹ 2,168 | ₹ 2,172 |
| November 2027 | ₹ 2,174 | ₹ 2,189 |
| December 2027 | ₹ 2,187 | ₹ 2,218 |
● The initial price target for Glenmark Pharmaceuticals Limited in 2027 is estimated to be ₹2057.
● With favorable market conditions, the mid-year price target for Glenmark Pharmaceuticals Ltd. could reach ₹2141.
● However, by the end of 2027, the price target is expected to reach ₹2218 considering bullish market trends.
Glenmark Pharmaceuticals Share Price Target 2028
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2028 | ₹ 2,197 | ₹ 2,221 |
| February 2028 | ₹ 2,193 | ₹ 2,207 |
| March 2028 | ₹ 2,205 | ₹ 2,221 |
| April 2028 | ₹ 2,227 | ₹ 2,267 |
| May 2028 | ₹ 2,258 | ₹ 2,271 |
| June 2028 | ₹ 2,270 | ₹ 2,306 |
| July 2028 | ₹ 2,310 | ₹ 2,346 |
| August 2028 | ₹ 2,339 | ₹ 2,364 |
| September 2028 | ₹ 2,322 | ₹ 2,339 |
| October 2028 | ₹ 2,331 | ₹ 2,340 |
| November 2028 | ₹ 2,338 | ₹ 2,352 |
| December 2028 | ₹ 2,352 | ₹ 2,381 |
● The initial price target for Glenmark Pharmaceuticals Limited in 2028 is estimated to be ₹2221.
● With favorable market conditions, the mid-year price target for Glenmark Pharmaceuticals Ltd. could reach ₹2306.
● However, by the end of 2028, the price target is expected to reach ₹2381 considering bullish market trends.
Glenmark Pharmaceuticals Share Price Target 2029
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2029 | ₹ 2,360 | ₹ 2,384 |
| February 2029 | ₹ 2,357 | ₹ 2,370 |
| March 2029 | ₹ 2,368 | ₹ 2,382 |
| April 2029 | ₹ 2,388 | ₹ 2,431 |
| May 2029 | ₹ 2,422 | ₹ 2,433 |
| June 2029 | ₹ 2,435 | ₹ 2,468 |
| July 2029 | ₹ 2,472 | ₹ 2,511 |
| August 2029 | ₹ 2,511 | ₹ 2,528 |
| September 2029 | ₹ 2,520 | ₹ 2,602 |
| October 2029 | ₹ 2,541 | ₹ 2,627 |
| November 2029 | ₹ 2,563 | ₹ 2,651 |
| December 2029 | ₹ 2,592 | ₹ 2,683 |
● The initial price target for Glenmark Pharmaceuticals Limited in 2029 is estimated to be ₹2384.
● With favorable market conditions, the mid-year price target for Glenmark Pharmaceuticals Ltd. could reach ₹2468.
● However, by the end of 2029, the price target is expected to reach ₹2683 considering bullish market trends.
Glenmark Pharmaceuticals Share Price Target 2030
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2030 | ₹ 2,623 | ₹ 2,718 |
| February 2030 | ₹ 2,623 | ₹ 2,718 |
| March 2030 | ₹ 2,628 | ₹ 2,725 |
| April 2030 | ₹ 2,639 | ₹ 2,739 |
| May 2030 | ₹ 2,654 | ₹ 2,758 |
| June 2030 | ₹ 2,676 | ₹ 2,780 |
| July 2030 | ₹ 2,700 | ₹ 2,808 |
| August 2030 | ₹ 2,732 | ₹ 2,843 |
| September 2030 | ₹ 2,768 | ₹ 2,883 |
| October 2030 | ₹ 2,814 | ₹ 2,931 |
| November 2030 | ₹ 2,866 | ₹ 2,987 |
| December 2030 | ₹ 2,916 | ₹ 3,040 |
● The initial price target for Glenmark Pharmaceuticals Limited in 2030 is estimated to be ₹2718.
● With favorable market conditions, the mid-year price target for Glenmark Pharmaceuticals Ltd. could reach ₹2780.
● However, by the end of 2030, the price target is expected to reach ₹3040 considering bullish market trends.
Glenmark Pharmaceuticals Share Price Target 2040
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2040 | ₹ 9,227 | ₹ 10,258 |
| February 2040 | ₹ 9,227 | ₹ 10,258 |
| March 2040 | ₹ 9,245 | ₹ 10,284 |
| April 2040 | ₹ 9,282 | ₹ 10,335 |
| May 2040 | ₹ 9,338 | ₹ 10,407 |
| June 2040 | ₹ 9,413 | ₹ 10,492 |
| July 2040 | ₹ 9,498 | ₹ 10,597 |
| August 2040 | ₹ 9,610 | ₹ 10,729 |
| September 2040 | ₹ 9,739 | ₹ 10,878 |
| October 2040 | ₹ 9,899 | ₹ 11,061 |
| November 2040 | ₹ 10,082 | ₹ 11,271 |
| December 2040 | ₹ 10,259 | ₹ 11,474 |
● The initial price target for Glenmark Pharmaceuticals Limited in 2040 is estimated to be ₹10258.
● With favorable market conditions, the mid-year price target for Glenmark Pharmaceuticals Ltd. could reach ₹10492.
● However, by the end of 2040, the price target is expected to reach ₹11474 considering bullish market trends.
Glenmark Pharmaceuticals Share Price Target 2050
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2050 | ₹ 32,461 | ₹ 38,712 |
| February 2050 | ₹ 32,461 | ₹ 38,712 |
| March 2050 | ₹ 32,526 | ₹ 38,809 |
| April 2050 | ₹ 32,656 | ₹ 39,003 |
| May 2050 | ₹ 32,852 | ₹ 39,276 |
| June 2050 | ₹ 33,115 | ₹ 39,594 |
| July 2050 | ₹ 33,413 | ₹ 39,990 |
| August 2050 | ₹ 33,807 | ₹ 40,490 |
| September 2050 | ₹ 34,263 | ₹ 41,052 |
| October 2050 | ₹ 34,825 | ₹ 41,742 |
| November 2050 | ₹ 35,470 | ₹ 42,535 |
| December 2050 | ₹ 36,090 | ₹ 43,301 |
● The initial price target for Glenmark Pharmaceuticals Limited in 2050 is estimated to be ₹38712.
● With favorable market conditions, the mid-year price target for Glenmark Pharmaceuticals Ltd. could reach ₹39594.
● However, by the end of 2050, the price target is expected to reach ₹43301 considering bullish market trends.
Glenmark Pharmaceuticals Ltd. Chart Online
LIC India Share Price Target: Long-term Forecast & Analysis
LIC stands for Life Insurance Corporation of India. It started its operations as a corporate firm after the LIC Act came into effect in July 1956. READ MORE
Recommendations: Should I invest in Glenmark Pharmaceuticals Limited stock or sell it?
Over the years, investment in the pharmaceutical companies has yielded high returns, especially because of expanding global health care needs and access to health care around the world. Such factors include an increasing aging population, increasing rate of chronic diseases, and increased health consciousness. Furthermore, the pharmaceutical industry has been able to remain profitable in periods of economic crisis and market instability, therefore it can be viewed as high risk low return ratio.
Analyzing the situation for Glenmark Pharmaceuticals Ltd. , it can be stated that the company has good future prospects. Investments into research and development, innovation, and diversification, including the emphasis on generics and specialty drugs will secure the company’s long-term growth. New geographies, alliances, and product/services development are the planned tactics that could propel Glenmark’s revenues and profit margins in the next few years.
It will be seen from the following stock market forecasts and analysis that Glenmark Pharmaceuticals Ltd. share will prove to be a positive change. Based on data on the company under review and its industry, it is possible to state that shares of the enterprise can be considered a profitable investment. Shares may present value for investors particularly when Glenmark relies on its competencies on the pharmaceutical sector toward becoming more reliable and profitable.
Therefore based on the overall positive market trend analysis for the pharma industry and strategic positioning of Glenmark pharmaceuticals, the investors can build a long term position in the shares of the company. Nevertheless, like any investment, one needs to do own research and weigh the pros and cons according to his/her individual goals and tolerance on risk.
Frequently Asked Questions (FAQ’s)
What is the Glenmark Pharmaceuticals share price target for 2025?
As per our stock forecast, Glenmark Pharmaceuticals share price target can be up to ₹1891 in 2025.
What is Glenmark Pharmaceuticals stock projected to be worth in 5 years?
Our estimates show that Glenmark Pharmaceuticals stock price could reach ₹2683 in the next 5 years.
What is the Glenmark Pharmaceuticals share price target for 2030?
As per our stock forecast, Glenmark Pharmaceuticals share price target can be up to ₹3040 in 2030.
What is Glenmark Pharmaceuticals stock projected to be worth in 10 years?
Our estimates show that Glenmark Pharmaceuticals stock price could reach ₹5280 in the next 10 years.
What is the Glenmark Pharmaceuticals share price target for 2035?
As per our stock forecast, Glenmark Pharmaceuticals share price target can be up to ₹6030 in 2035.
What is the Glenmark Pharmaceuticals share price target for 2040?
As per our stock forecast, Glenmark Pharmaceuticals share price target can be up to ₹11474 in 2040.
What is the Glenmark Pharmaceuticals share price target for 2050?
As per our stock forecast, Glenmark Pharmaceuticals share price target can be up to ₹43301 in 2050.
Price Prediction Methodology
The following tools are utilized for making predictions:
- Consensus and Expert Opinion: Forecasts are also informed by the consensus of expert opinions, providing a well-rounded perspective.
- Technical Analysis: This fundamental tool involves studying price charts and employing various indicators to forecast future price movements. The analysis is primarily conducted on medium- and long-term time frames for enhanced accuracy.
- Statistical Methods: These are used to evaluate the likelihood, type, and intensity of fundamental factors that could influence price fluctuations.
- Predictive Modeling: This approach leverages statistical algorithms to forecast future prices based on historical data patterns.
